Price (delayed)
$2.265
Market cap
$60.72M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.34
Enterprise value
$40.3M
Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop
There are no recent dividends present for SYRS.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.